Akari Common Stock Shares Outstanding vs Cash And Short Term Investments Analysis
| AKTX Stock | USD 1.19 0.02 1.65% |
Akari Therapeutics financial indicator trend analysis is way more than just evaluating Akari Therapeutics PLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akari Therapeutics PLC is a good investment. Please check the relationship between Akari Therapeutics Common Stock Shares Outstanding and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Common Stock Shares Outstanding vs Cash And Short Term Investments
Common Stock Shares Outstanding vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Akari Therapeutics PLC Common Stock Shares Outstanding account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between Akari Therapeutics' Common Stock Shares Outstanding and Cash And Short Term Investments is 0.73. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Akari Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Akari Therapeutics' Common Stock Shares Outstanding and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Akari Therapeutics PLC are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Common Stock Shares Outstanding i.e., Akari Therapeutics' Common Stock Shares Outstanding and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.73 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Akari Therapeutics PLC balance sheet. This account contains Akari Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Akari Therapeutics PLC fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from Akari Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akari Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Selling General Administrative is likely to drop to about 10.8 K in 2024. Tax Provision is likely to drop to about (3 M) in 2024
| 2021 | 2022 | 2023 | 2024 (projected) | Net Interest Income | 10.6K | 45.9K | 41.3K | 70.5K | Interest Income | 10.6K | 45.9K | 41.3K | 39.3K |
Akari Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Akari Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Akari Therapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 915.5K | 1.6M | 2.1M | 3.1M | 4.9M | 4.7M | |
| Total Assets | 10.3M | 17.6M | 11.6M | 13.8M | 4.4M | 4.1M | |
| Other Current Liab | 4.2M | 1.8M | 4.3M | 11.1M | 4.6M | 5.9M | |
| Total Current Liabilities | 5.5M | 5.2M | 6.1M | 12.0M | 4.6M | 7.9M | |
| Total Stockholder Equity | 3.8M | 12.4M | 5.6M | 1.8M | (229K) | (217.6K) | |
| Net Debt | (5.7M) | (14.1M) | (9.4M) | (13.2M) | (3.8M) | (4.0M) | |
| Retained Earnings | (138.2M) | (156.6M) | (199.7M) | (217.5M) | (227.5M) | (216.1M) | |
| Accounts Payable | 1.2M | 3.4M | 1.8M | 946.7K | 1.7K | 1.6K | |
| Cash | 5.7M | 14.1M | 9.4M | 13.2M | 3.8M | 3.7M | |
| Cash And Short Term Investments | 5.7M | 14.1M | 9.4M | 13.2M | 3.8M | 3.7M | |
| Common Stock Total Equity | 22.9M | 23.7M | 32.0M | 384.7K | 442.4K | 420.3K | |
| Liabilities And Stockholders Equity | 10.3M | 17.6M | 11.6M | 13.8M | 4.4M | 4.1M | |
| Non Current Liabilities Total | 1.0M | 3.4M | 4.3M | 946.7K | 1.1M | 1.1M | |
| Other Stockholder Equity | 122.3M | 179.6M | 205.3M | 219.3M | 174.8M | 116.1M | |
| Total Liab | 6.5M | 5.2M | 6.1M | 12.0M | 4.6M | 8.1M | |
| Total Current Assets | 10.3M | 17.6M | 11.6M | 13.8M | 4.3M | 4.1M | |
| Accumulated Other Comprehensive Income | (12.2M) | (10.9M) | (541.0K) | (770.8K) | 51.2M | 53.7M | |
| Common Stock | 32.0M | 385K | 476.0K | 744.5K | 1.3M | 1.3M | |
| Non Current Assets Total | 35K | 27K | 22.9K | 16.9K | 14K | 13.3K | |
| Property Plant And Equipment Gross | 20.4K | 5.0K | 172K | 164.9K | 197.8K | 207.7K | |
| Net Tangible Assets | 3.1M | (1.8M) | 9.4M | 5.5M | 5.0M | 4.7M | |
| Other Current Assets | 1.0M | 521.9K | 90.3K | 99.5K | 496K | 483.0K | |
| Intangible Assets | 30K | 27K | 22.9K | 16.9K | 14.0 | 13.3 | |
| Net Invested Capital | (1.8M) | 9.4M | 5.6M | 1.8M | 1.6M | 1.5M | |
| Net Working Capital | (1.8M) | 9.4M | 5.5M | 1.8M | 1.6M | 1.5M | |
| Capital Stock | 32.0M | 384.7K | 476.0K | 744.5K | 670.0K | 636.5K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Akari Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Akari Therapeutics' short interest history, or implied volatility extrapolated from Akari Therapeutics options trading.
Pair Trading with Akari Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akari Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Akari Stock
| 0.94 | RZLT | Rezolute Financial Report 9th of May 2024 | PairCorr |
| 0.87 | RVMD | Revolution Medicines Financial Report 13th of May 2024 | PairCorr |
| 0.83 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
| 0.81 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
| 0.76 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
The ability to find closely correlated positions to Akari Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akari Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akari Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akari Therapeutics PLC to buy it.
The correlation of Akari Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akari Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akari Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akari Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Akari Stock analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Akari Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akari Therapeutics. If investors know Akari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akari Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.04) | Return On Assets (1.16) | Return On Equity (12.81) |
The market value of Akari Therapeutics PLC is measured differently than its book value, which is the value of Akari that is recorded on the company's balance sheet. Investors also form their own opinion of Akari Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akari Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akari Therapeutics' market value can be influenced by many factors that don't directly affect Akari Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akari Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akari Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akari Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.